QQQ   350.76 (+0.68%)
AAPL   177.70 (+1.29%)
MSFT   331.96 (-0.28%)
META   265.55 (+1.34%)
GOOGL   123.89 (-0.58%)
AMZN   121.78 (+1.39%)
TSLA   199.64 (+3.35%)
NVDA   404.87 (+3.96%)
NIO   7.40 (-3.90%)
BABA   78.50 (-3.05%)
AMD   126.31 (-0.57%)
T   15.66 (+1.03%)
F   12.65 (+4.63%)
MU   72.70 (-1.66%)
CGC   0.87 (-0.60%)
GE   102.20 (-0.53%)
DIS   87.37 (-1.04%)
AMC   4.54 (-2.16%)
PFE   37.08 (-1.38%)
PYPL   61.29 (+1.78%)
NFLX   393.81 (+3.94%)
QQQ   350.76 (+0.68%)
AAPL   177.70 (+1.29%)
MSFT   331.96 (-0.28%)
META   265.55 (+1.34%)
GOOGL   123.89 (-0.58%)
AMZN   121.78 (+1.39%)
TSLA   199.64 (+3.35%)
NVDA   404.87 (+3.96%)
NIO   7.40 (-3.90%)
BABA   78.50 (-3.05%)
AMD   126.31 (-0.57%)
T   15.66 (+1.03%)
F   12.65 (+4.63%)
MU   72.70 (-1.66%)
CGC   0.87 (-0.60%)
GE   102.20 (-0.53%)
DIS   87.37 (-1.04%)
AMC   4.54 (-2.16%)
PFE   37.08 (-1.38%)
PYPL   61.29 (+1.78%)
NFLX   393.81 (+3.94%)
QQQ   350.76 (+0.68%)
AAPL   177.70 (+1.29%)
MSFT   331.96 (-0.28%)
META   265.55 (+1.34%)
GOOGL   123.89 (-0.58%)
AMZN   121.78 (+1.39%)
TSLA   199.64 (+3.35%)
NVDA   404.87 (+3.96%)
NIO   7.40 (-3.90%)
BABA   78.50 (-3.05%)
AMD   126.31 (-0.57%)
T   15.66 (+1.03%)
F   12.65 (+4.63%)
MU   72.70 (-1.66%)
CGC   0.87 (-0.60%)
GE   102.20 (-0.53%)
DIS   87.37 (-1.04%)
AMC   4.54 (-2.16%)
PFE   37.08 (-1.38%)
PYPL   61.29 (+1.78%)
NFLX   393.81 (+3.94%)
QQQ   350.76 (+0.68%)
AAPL   177.70 (+1.29%)
MSFT   331.96 (-0.28%)
META   265.55 (+1.34%)
GOOGL   123.89 (-0.58%)
AMZN   121.78 (+1.39%)
TSLA   199.64 (+3.35%)
NVDA   404.87 (+3.96%)
NIO   7.40 (-3.90%)
BABA   78.50 (-3.05%)
AMD   126.31 (-0.57%)
T   15.66 (+1.03%)
F   12.65 (+4.63%)
MU   72.70 (-1.66%)
CGC   0.87 (-0.60%)
GE   102.20 (-0.53%)
DIS   87.37 (-1.04%)
AMC   4.54 (-2.16%)
PFE   37.08 (-1.38%)
PYPL   61.29 (+1.78%)
NFLX   393.81 (+3.94%)
CVE:CZO

Ceapro (CZO) Stock Forecast, Price & News

C$0.45
-0.01 (-2.17%)
(As of 09:38 AM ET)
Compare
Today's Range
C$0.45
▼
C$0.45
50-Day Range
C$0.43
▼
C$0.65
52-Week Range
C$0.42
▼
C$0.82
Volume
5,000 shs
Average Volume
31,122 shs
Market Capitalization
C$35.21 million
P/E Ratio
7.50
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsHeadlines

CZO stock logo

About Ceapro (CVE:CZO) Stock

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. It operates in two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry. The Active Ingredient Product Technology Industry segment develops proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment is involved in the development and commercialization of anti-aging products derived from natural active ingredients sold directly to the end-user primarily through online website sales and through select natural products stores. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Receive CZO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter.

CZO Stock News Headlines

May 25, 2023 | stockhouse.com
Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update
May 13, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc up on Friday (CZO)
May 30, 2023 | Edge On The Street (Ad)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
May 3, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc down on Tuesday (CZO)
May 3, 2023 | finance.yahoo.com
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration
April 22, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc down on Friday (CZO)
April 21, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc up on Thursday (CZO)
April 19, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc up on Tuesday (CZO)
May 30, 2023 | Edge On The Street (Ad)
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
April 12, 2023 | finance.yahoo.com
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
April 11, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc down on Monday (CZO)
April 6, 2023 | theglobeandmail.com
Closing Bell: Ceapro Inc flat on Thursday (CZO)
February 20, 2023 | finance.yahoo.com
Is Weakness In Ceapro Inc. (CVE:CZO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
November 11, 2022 | uk.finance.yahoo.com
Returns At Ceapro (CVE:CZO) Are On The Way Up
October 13, 2022 | finance.yahoo.com
Ceapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed Carriers
October 12, 2022 | seekingalpha.com
Ceapro: A Moat In Oat
September 12, 2022 | nz.finance.yahoo.com
Is Ceapro Inc.'s (CVE:CZO) Latest Stock Performance A Reflection Of Its Financial Health?
August 24, 2022 | finance.yahoo.com
Ceapro Inc. Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate Update
August 16, 2022 | reuters.com
CZO.V - Ceapro Inc | Stock Price & Latest News | Reuters
June 4, 2022 | finance.yahoo.com
Ceapro (CVE:CZO) Has More To Do To Multiply In Value Going Forward
May 18, 2022 | stockhouse.com
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update
May 11, 2022 | nz.finance.yahoo.com
Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization
May 3, 2022 | finance.yahoo.com
A Look At The Intrinsic Value Of Ceapro Inc. (CVE:CZO)
April 19, 2022 | stockhouse.com
Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors
March 2, 2022 | finance.yahoo.com
Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry
December 26, 2021 | news.yahoo.com
Ceapro's (CVE:CZO) Returns On Capital Not Reflecting Well On The Business
September 8, 2021 | stockhouse.com
Ceapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment Conference
See More Headlines
Receive CZO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter.

CZO Company Calendar

Today
5/30/2023
Next Earnings (Estimated)
8/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:CZO
CUSIP
N/A
CIK
N/A
Web
www.ceapro.com
Phone
+1-780-4214555
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C$0.06
Trailing P/E Ratio
7.50
Forward P/E Ratio
11.25
P/E Growth
N/A
Net Income
C$4.40 million
Net Margins
23.34%
Pretax Margin
N/A
Return on Equity
14.66%
Return on Assets
9.99%

Debt

Debt-to-Equity Ratio
8.11
Current Ratio
9.80
Quick Ratio
18.88

Sales & Book Value

Annual Sales
C$18.84 million
Price / Sales
1.87
Cash Flow
C$0.11 per share
Price / Cash Flow
3.94
Book Value
C$0.41 per share
Price / Book
1.10

Miscellaneous

Outstanding Shares
78,250,000
Free Float
N/A
Market Cap
C$35.21 million
Optionable
Not Optionable
Beta
1.48

Key Executives

  • Mr. Gilles R. Gagnon ICD.D (Age 69)
    M.B.A., M.Sc., MBA, CEO, Pres & Director
    Comp: $560k
  • Ms. Stacy Prefontaine CPA
    CA, CFO & Corp. Sec.
  • Dr. Bernhard Seifried
    Sr. Director of Research & Technology
  • Ms. Sigrun Watson
    Chief Revenue Officer

Key Competitors

View All Competitors













CZO Stock - Frequently Asked Questions

How have CZO shares performed in 2023?

Ceapro's stock was trading at C$0.59 on January 1st, 2023. Since then, CZO stock has decreased by 23.7% and is now trading at C$0.45.
View the best growth stocks for 2023 here.

When is Ceapro's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 23rd 2023.
View our CZO earnings forecast.

What other stocks do shareholders of Ceapro own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceapro investors own include Franco-Nevada (FNV), Badger Daylighting (BAD), FLYHT Aerospace Solutions (FLY), Invesco Water Resources ETF (PHO), Russel Metals (RUS), ServisFirst Bancshares (SFBS), Chemtrade Logistics Income Fund (CHE.UN), Bausch Health Companies (BHC), BCE (BCE) and BlackBerry (BB).

What is Ceapro's stock symbol?

Ceapro trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CZO."

How do I buy shares of Ceapro?

Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Ceapro's stock price today?

One share of CZO stock can currently be purchased for approximately C$0.45.

How much money does Ceapro make?

Ceapro (CVE:CZO) has a market capitalization of C$35.21 million and generates C$18.84 million in revenue each year. The company earns C$4.40 million in net income (profit) each year or C$0.06 on an earnings per share basis.

How can I contact Ceapro?

Ceapro's mailing address is 7824 51 Ave NW, EDMONTON, AB T6E 6W2, Canada. The official website for the company is www.ceapro.com. The company can be reached via phone at +1-780-4214555.

This page (CVE:CZO) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -